Hormone replacement use, arterial distensibility, cardiac structure and circadian blood pressure profile in menopausal women

Blood Pressure

Volumn 14, Issue 1, 2005, Pages 12-20

  Wong, Julia ^a   Wong, Shirley ^a   Handa, S Paul ^b   Abbott, E Carl ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Atlantic Health Sciences Corporation   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

24 h blood pressure; Aortic distensibility; HRT; LVMI; Menopause

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROGESTERONE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT VENTRICLE MASS; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; ARTERIES; BLOOD PRESSURE; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DRUG EVALUATION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LIPIDS; MENOPAUSE; MIDDLE AGED; VASCULAR RESISTANCE;

EID: 15944385689     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050510008797     Document Type: Article

References (59)

1. Yosefy C, Dicker D, Viskoper JR, et al. The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality. Prev Med. 2003;37(6 Pt 1):571-6.
2. Flack JM, Casciano R, Casciano J, et al. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface. 2002;15:28-36.
3. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-9.
4. Scuteri A, Lakatta EG, Bos AJG, Fleg JL. Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women. Aging Clin Exp Res. 2001;13:122-30.
5. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-91.
6. Lieberman EH, Gerhard MD, Uehara A, et al. Estrogen improves endothelium-dependent flow mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-41.
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen-progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33.
8. Manson J, Hsia J, Johson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523-34.
9. Hulley S, Grady D, Furberg C, Herrington D, Riggs B, Vittingh E, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention in postmenopausal women. JAMA. 1998;280:605-13.
10. Grodstein F, Manson J, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of post-menopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133:933-41.
11. Miura S, Tanaka E, Mori A, et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas. 2003;45:293-8.
12. De Meersman RE, Zion AS, Giardina EGV, Weir JP, Lieberman JS, Downey JA. Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women. Am J Physiol. 1998;274:H1539-44.
13. Westendorp ICD, de Kleijn MJJ, Bots ML, et al. The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial. Atherosclerosis. 2000;152:149-57.
14. Gorgulu S, Eren M, Celik S, et al. The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function. Acta Cardiol. 2003;58:1-8.
15. Lim WK, Wren B, Jepson N, Roy S, Caplan G. Effect of hormone replacement therapy on left ventricular hypertrophy. Am J Cardiol. 1999;83:1132-4, A9.
16. Light KC, Hindlerliter AL, West SG, et al. Hormone replacement improves homodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women. J Hypertens. 2001;19:269-78.
17. Sites C, Tischler MD, Blackman JA, et al. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril. 1999;71:137-43.
18. Snabes MC, Payne JP, Kopelen HA, Dunn JK, Young RL, Zoghbi WA. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo controlled, crossover trial. Obstet Gynecol. 1997;89:332-9.
19. Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women. Am J Hypertens. 2000;13:1039-41.
20. Mercuro G, Zoncu S, Piano D, et al. Estradiol-17 beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens. 1998;11(8 Pt 1):909-13.
21. Mills PJ, Farag NH, Matthews S, Nelesen RA, Berry CC, Dimsdale JE. Hormone replacement therapy does not affect 24-h ambulatory blood pressure in healthy non-smoking postmenopausal women. Blood Press Monit. 2003;8:57-61.
22. Handa SP, Wong J, Wolf HK. The relationship of plasma norepinephrine levels and aortic distensibility in elderly with isolated systolic hypertension. Am J Hypertens. 1995;8:422-5.
23. Stefandis C, Stratos C, Bourdoulos H, Kourouklis C, Toutoyzas P. Distensibility of the ascending aorta: comparison of invasive and noninvasive techniques in healthy men and in men with coronary artery disease. Eur Heart J. 1990;11:990-6.
24. Devereux RB, Reichek N. Left ventricular hypertrophy. Cardiovasc Res. 1980;1:55-61.
25. Pierdomenico SD, Bucci A, Constantini F, et al. Circadian blood change changes and myocardial ischemia in hypertensive patients with coronary artery disease. J Am Coll Cardiol. 1998;32:1627-34.
26. Verdechhia P, Schillaci G, Borgioni C, et al. Altered circadian blood pressure profile and prognosis. Blood Press Monit. 1997;2:347-52.
27. Rajkumar C, Kingwell BA, Cameron J, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol. 1997;30:350-6.
28. Sites CK, Tischler MD, Blackman JA, et al. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril. 1991;71: 137-43.
29. Hayward CS, Samarask K, Campbell L, Kelly RP. Effect of combination of hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women. Am J Hypertens. 2001; 14(7 Pt 1):699-703.
30. Akkada AA, Halligan AW, Abrams K, al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol. 1997;89:97-103.
31. Manhem K, Ahlm H, Milsom I, Svebsson A. Transdermal oestrogen reduces daytime blood pressure in hypertensive women. J Human Hypertens. 1998;12:323-7.
32. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO 3rd, Quyyumi AA, Panza JA. Effect of cooper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertens. 1995;26:863-8.
33. Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab. 2000;85:1577-83.
34. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers. A J Epidemiol. 1996;143:971-8.
35. Egeland GM, Kuller LH, Matthews KA, Kelsey SF, Cauley J, Guzick D. Premenopausal determinants of menopausal estrogen use. Preventive Medicine. 1991;20:343-9.
36. Dallongeville J, Marceaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis. 1995;118:123-33.
37. Lip GY, Beevers M, Churchill D, Beevers DG. Hormone replacement therapy and blood pressure in hypertensive women. J Human Hypertens. 1994;8:491-4.
38. Czarnecka D, Kawecka-Jaszoz K, Olszanecka A, et al. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. Med Sci Monit. 2004;10:CR55-61.
39. Safar ME. Pulse pressure in essential hypertension: clinical and therapeutic implications. J Hypertens. 1989;7:769-76.
40. Cacciatore B, Paakkari I, Hasselblatt R, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol. 2001;184:904-9.
41. Verdecchia P, Schillaci G, Gatteschi C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation. 1993;88:652-5.
42. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertens. 1994;24:793-801.
43. McGrath BP, Liang YL, Teede H, Shiel LM, Cameron JD, Dart A. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy. Arterioscler Thromb Vasc Biol. 1998;18:1149-56.
44. Dart AM, Lacombe A, Yeoh JK, Cameron JD, Jennings GL, Esmore D. Aortic distensibility in patients with isolated hypercholesterolemia, coronary heart disease, or cardiac transplant. Lancet. 1991;338:270-3.
45. Cameron J, Dart A. Pulse wave velocity as a marker of vascular disease. Lancet. 1996;348:1586.
46. Kangro T, Henriksen E, Jonason T, et al. Effect of menopause on left ventricular filling in 50-year-old women. Am J Cardiol. 1995;76:1093-6.
47. Kessel H, Kamp O, Mijatovic V, van Baal WM, Visser CA, van der Mooren MJ. Effects of 15 months of 17β-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy post-menopausal women. Am J Obstet Gynecol. 2001;184:910-6.
48. Pines A, Fisman EZ, Shapiro I, et al. Exercise echocardiography in postmenopausal women hormone users with mild systemic hypertension. Am J Cardiol. 1996;78:1385-9.
49. Fleg JL. Alterations in cardiovascular structure and function with advancing age. Am J Cardiol. 1986;57:33-44C.
50. Arnett DK, Evans GW, Riley W. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol. 1994;140: 669-82.
51. Cuspidi C, Michev I, Meani S, et al. Non-dipper treated hypertensive patients do not have increased cardiac structural alterations. Cardiovascular Ultrasound. 2003;1:1-15.
52. Pickering TG, James GD. Determinants and consequences of diurnal rhythm of blood pressure. Am J Hypertens. 1993;6:166-9S.
53. Devereux RB, Pickering TG. Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension. J Hypertens. 1991;9: S34-8.
54. Girerd X, Giannattasio C, Moulin C, Safar M, Mancia G, Laurent S. Regression of radial arterial wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol. 1998;31:1064-73.
55. Safar M, van Bortel L, Struijker-Boudier H. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Vasc Res. 1997;34:67-81.
56. Ting CT, Chen CH, Chang SM, Yin FC. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. Hypertens. 1995;26:524-30.
57. De Cesaris R, Ranieri G, Filitti V, Andriani A. Large artery compliance in essential hypertension: effects of calcium antagonism and beta-blocking. Am J Hypertens. 1992;5: 624-8.
58. O'Connell MB. Pharmacokinetic and pharmacologic variation between different estrogen products. J Clin Pharmacol. 1995;35 Suppl 9:18-24S.
59. Manning G, Rushton L, Donnelly R, Miller-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens. 2000;13:1035-8.